100% Legal, Non-psychoactive, Hemp-Derived cannabidiol (CBD)
What is CBD? Cannabidiol, also known as CBD, is one of over 60+ naturally occurring cannabinoid compounds found in Cannabis. CBD oil is derived from an organic substance formed in the plant’s secretions. Unlike THC, CBD does not cause any feeling of “high,” which contributes to its legalization across the United States. CBD does not typically have any immediately noticeable effect.
What does it help treat? CBD is a natural anti-inflammatory. CBD Cream is most popularly used for localized pain relief, muscle soreness, tension, and inflammation.
Some attributes of CBD are: Antibacterial, Inhibits cancer cell growth, Neuro-protective, Promotes bone growth, Reduces seizures and convulsions, Reduces blood sugar levels, Reduces inflammation, Reduces risk of artery blockage, Reduces nausea, Relieves pain, Relieves anxiety, Slows bacterial growth, Treats psoriasis, Vasorelaxant.
Where does our CBD come from? Our CBD oil is extracted from hemp from Oregon, a legally grown plant that is low in THC. Lab tests with no traceable THC (Rest assured you will not test positive on drug testing)
Adding to the lack of confusion is the federal position, which my colleague, Daniel Shortt, recently discussed. In a nutshell, the FDA may view a cosmetic product as prohibited if its ingredients or the product itself is unsafe, or if it is intended to be used in a way that makes it a “drug” (i.e., it is “intended to affect the structure or function of the body, or to diagnose, cure, mitigate, treat or prevent disease”). In other words, the FDA hasn’t taken as hardline of a stance against cosmetics as it has against foods and unapproved drugs, but we still have a sense of the FDA’s willingness to crack down on products that aren’t safe or that make medical claims.
In spite of the general confusion in California and with the FDA’s policy statement, at least some clarity may soon be taken away if a new piece of California legislation, AB-228, is passed. If passed in its current form, AB-228 would state:
A cosmetic is not adulterated because it includes industrial hemp . . . or cannabinoids, extracts, or derivatives from industrial hemp. The sale of cosmetics that include industrial hemp or cannabinoids, extracts, or derivatives from industrial hemp shall not be restricted or prohibited based solely on the inclusion of industrial hemp or cannabinoids, extracts, or derivatives from industrial hemp.
What this would mean is that if passed, CDPH could not use the CA Sherman Law to find that CBD-containing topicals adulterated simply by virtue of containing Hemp CBD (the same would also apply to foods). This may lead to more clarity for California CBD companies who have topical products.
That said, it’s not yet clear whether the CDPH would continue to follow federal law even in spite of AB-228 passing. The state may find itself in a position of ignoring federal positions (like it has done with marijuana), or the CDPH may continue to follow federal agencies. Even the California Attorney General’s office has recognized that this could happen:
Even if it [AB-228 passes], it is not clear whether changing California law on this adulteration issue would be sufficient to alter the decision calculus of the CDPH, which has to this point relied on the FDA’s interpretation of federal law. That is, it might be the conclusion of these agencies that federal law still prohibits adding CBD to food or dietary supplements, even where derived from industrial hemp.
Though this is just speculation, I don’t think that the CDPH will follow the FDA if AB-228 passes. The FDA’s policy guidelines are so broadly written that they would prohibit the introduction of marijuana into food products in California—yet we don’t see any state agencies pulling those products. This includes products that are manufactured by CDPH licensees.
It’s also important to point out that even if AB-228 passes, the CDPH will be able to find Hemp CBD cosmetic products “misbranded”. However, this is also probably less likely to occur except in cases where products make unsubstantiated or false claims or are advertised in a deceptive manner. This may very well happen for some Hemp CBD products, which is why it’s important to consult with an experienced attorney prior to marketing or advertising new products.